NCT00103038 2022-06-09
Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases
OHSU Knight Cancer Institute
Phase NA Completed
Clinical Trials
3 trialsNCT02590497 2018-01-31
Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery
Ohio State University Comprehensive Cancer Center
Phase NA Withdrawn
NCT00660543 2017-05-16
MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy
OHSU Knight Cancer Institute
Phase NA Completed